safety of glp 1 receptor agonists Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review GLP-1 agonist efficacy and Comparative efficacy and safety of

Description

Belli, M

45,46 As shown in Figure 2 , GLP-1RAs penetrate the blood-brain barrier and directly activate GLP-1 receptors in the hypothalamus, especially within the ARH nucleus, a key center for appetite regulation

A dosage calculator simplifies this transition

We adjusted for patient age, sex, race, ethnicity, Social Vulnerability Index quintile, starting BMI, weight change after treatment, history of insulin usage, and starting HbA1c

First approved to treat type 2 diabetes, GLP-1 based drugs are now used to aid weight loss in obesity and to help lower the risk of heart failure and treat obstructive sleep apnea, a common breathing-related sleep disorder, in people with obesity